Infinix NOTE 60 Ultra and NOTE 60 Pro receive globally recognized design awards (Image Credit: PRNewswire)
IGEL Appoints James Millington as Field CTO for Healthcare in EMEA (Image Credit: PRNewswire)

Micro Imaging Technology Announces Acquisition of Cellmyx

Micro Imaging Technology Announces Acquisition of Cellmyx (Image Credit: Micro Imaging Technology official website)
Micro Imaging Technology Announces Acquisition of Cellmyx (Image Credit: Micro Imaging Technology official website)

Micro Imaging technology, Inc. (“MIT”) a California-based public company symbol (MMTC), recently announced the acquisition of Cellmyx, a great addition to MIT’s portfolio of companies in the “Aesthetic, Cosmetic Surgery and Regenerative Medicine Space.”

For 25 years the name “Millennium Medical Technologies Inc.” DBA: Cellmyx, has been synonymous with quality and is known throughout the cosmetic surgical industry for product dependability. Company founder Greg Miles has strived to manufacture top of the line medical tools that run the gamut of application, aesthetics, and beyond. Regenerative intelliFat injectables offer a new frontier of research and invention, and Cellmyx is poised to lead the way in this exciting discipline.

The acquisition of Cellmyx is complementary to the acquisition of SaltMed/SaltFacial which closed in late December 2025. The combination of these two companies strengthens the ability to expand and manufacture its existing products not only nationally but also worldwide. Cellmyx, is an authority and leader on autologous adipose grafting and transfer, with a specialty in medical technologies for orthopedic physicians, pain management, and regenerative medicine, which received clearance in early 2023 for intelliFat BOD from the U.S. Food and Drug Administration (FDA) 510(k) (Ref.# K210528) ISO 13485#0136711 and MDSAP#0136710 Certification.

(Image Credit: Micro Imaging Technology and Cellmyx official websites)
(Image Credit: Micro Imaging Technology and Cellmyx official websites)

FDA has cleared the way for this groundbreaking new medical appliance and technology for use in orthopedic, plastic, and cosmetic surgery procedures. IntelliFat BOD successfully uses a patient’s own body fat, clinically referred to as adipose tissue, to aid in patient recovery and healing in all parts of the body (joint and ligament repair). MIT is committed and will continue to serve its existing and new customers with great service and support. MIT will continue to explore other opportunities in the aesthetics and regenerative space that can make a difference to humankind.

Source

For more similar news on acquisitions and partnerships, check links below:

AccuQuilt acquires June Tailor brand

Neolix Technologies Joins Autoware Foundation To Deliver Commercialized Autonomous 

Finastra partners with S&P Global Market Intelligence

(Visited 17 times, 1 visits today)

Share:

Facebook
Twitter
WhatsApp
LinkedIn

 

Comments are closed.

  • 4 Fintech Week Awards & Expo - 16 to 17 Sep 2026

Social Media

Most Popular

Atomic Mobile Supports Connectivity for International Media Covering the FIFA World Cup (Image Credit: Atomic Mobile LinkedIn page)
Atomic Mobile Strengthens Connectivity for FIFA World Cup Media Coverage
Changan Automobile announces partnership with the Portugal National Football Team (Image Credit: PRNewswire)
Changan Automobile Announces Partnership with the Portugal National Football Team
Death Wish Coffee Co.'s Power Surge (Image Credit: PRNewswire)
Death Wish Coffee Co. Introduces Power Surge
Vocelli Pizza Launches a New High Protein Pinsa Crust (Image Credit: PRNewswire)
Vocelli Introduces Protein-Rich Pinsa Pizza Crust

Related Posts